Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02531334 · ClinicalTrials.gov registry record · NA
Effects of TA-65, a Telomerase Activator on Metabolic Syndrome
A NA study, sponsored by University of Connecticut.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT02531334: Completed NA study, sponsored by University of Connecticut.
NCT02531334 is a NA study that has completed, run by University of Connecticut. The registered enrollment target is 40 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02531334, a NA study, has completed, sponsored by University of Connecticut.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
This study is being conducted to evaluate the efficacy of TA-65, a purified extract of Astragalus root, on insulin resistance, oxidative stress, and inflammation in individuals classified with metabolic syndrome.
Primary Outcome
The supplement is expected to decrease insulin resistance in metabolic syndrome patients
Interventions
- DIETARY_SUPPLEMENT TA-65
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2015-08 |
| Est. Completion | 2018-06 |
| Phase | NA |
What the finished NCT02531334 record still lists
NCT02531334 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 1 intervention - of which TA-65 is the first listed.
NCT02531334 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02531334 about?
NCT02531334 is a clinical study titled "Effects of TA-65, a Telomerase Activator on Metabolic Syndrome". This study is being conducted to evaluate the efficacy of TA-65, a purified extract of Astragalus root, on insulin resistance, oxidative stress, and inflammation in individuals classified with metabolic syndrome.
What is the current status of trial NCT02531334?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2015-08. Estimated completion is 2018-06.
What interventions are being tested in trial NCT02531334?
The interventions under investigation include: TA-65 (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02531334?
This trial is sponsored by University of Connecticut, which has 107 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02531334's enrollment target sits among peer trials
40 1447th of 2000 higher than 465 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia